Study links ultra-processed foods to higher metabolic disease risk

Consuming ultra-processed foods (UPFs) is linked to a higher risk of metabolic diseases like obesity and type 2 diabetes mellitus (T2DM), underscoring the need for dietary caution and policy adjustments.

NICE expands access of Paxlovid to further 1.4 million Covid-19 patients – Pharmaceutical Technology

Share this article Paxlovid saw peak global sales of $18.9bn in 2022. Image credit: Shutterstock/MargJohnsonVA. An additional 1.4 million people in England and Wales who

January 11, 2024

FDA approves J&J’s OPSYNVI for pulmonary arterial hypertension

Share this article Johnson & Johnson’s OPSYNVI is a single-tablet formulation comprising macitentan and tadalafil. Credit: Manuel Esteban / Shutterstock.com. The US Food and Drug

March 25, 2024

Windtree and Lee’s sign licence agreement for heart failure therapy

Share this article Istaroxime is intended to treat patients with acute heart failure and cardiogenic shock. Credit: Ahmet Misirligul/Shutterstock.com. Windtree Therapeutics and Lee’s Pharmaceutical have

January 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.